相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Distinct tau PET patterns in atrophy-defined subtypes of Alzheimer's disease
Rik Ossenkoppele et al.
ALZHEIMERS & DEMENTIA (2020)
Head-to-head comparison of tau positron emission tomography tracers [18F]flortaucipir and [18F]RO948
Ruben Smith et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)
Prospective longitudinal atrophy in Alzheimer's disease correlates with the intensity and topography of baseline tau-PET
Renaud La Joie et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Positron Emission Tomography Imaging With [18F]flortaucipir and Postmortem Assessment of Alzheimer Disease Neuropathologic Changes
Adam S. Fleisher et al.
JAMA NEUROLOGY (2020)
Diagnostic Performance of RO948 F 18 Tau Positron Emission Tomography in the Differentiation of Alzheimer Disease From Other Neurodegenerative Disorders
Antoine Leuzy et al.
JAMA NEUROLOGY (2020)
18F-MK-6240 PET for early and late detection of neurofibrillary tangles
Tharick A. Pascoal et al.
BRAIN (2020)
Is tau in the absence of amyloid on the Alzheimer's continuum?: A study of discordant PET positivity
Alexandra J. Weigand et al.
BRAIN COMMUNICATIONS (2020)
In Vivo Characterization and Quantification of Neurofibrillary Tau PET Radioligand F-18-MK-6240 in Humans from Alzheimer Disease Dementia to Young Controls
Tobey J. Betthauser et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Effect of Off-Target Binding on 18F-Flortaucipir Variability in Healthy Controls Across the Life Span
Suzanne L. Baker et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Essential TNM: a registry tool to reduce gaps in cancer staging information
Marion Pineros et al.
LANCET ONCOLOGY (2019)
Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease: A Longitudinal Study
Bernard J. Hanseeuw et al.
JAMA NEUROLOGY (2019)
Tau Subtypes of Alzheimer's Disease Determined in vivo Using Flortaucipir PET Imaging
Arnaud Charil et al.
JOURNAL OF ALZHEIMERS DISEASE (2019)
Longitudinal changes of tau PET imaging in relation to hypometabolism in prodromal and Alzheimer's disease dementia
K. Chiotis et al.
MOLECULAR PSYCHIATRY (2018)
Associations between [18F]AV1451 tau PET and CSF measures of tau pathology in a clinical sample
Renaud La Joie et al.
NEUROLOGY (2018)
Cerebrospinal fluid biomarkers measured by Elecsys assays compared to amyloid imaging
Suzanne E. Schindler et al.
ALZHEIMERS & DEMENTIA (2018)
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2018)
Longitudinal tau PET in ageing and Alzheimer's disease
Clifford R. Jack et al.
BRAIN (2018)
Discriminative Accuracy of [18F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative Disorders
Rik Ossenkoppele et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Monoamine oxidase B inhibitor, selegiline, reduces 18F-THK5351 uptake in the human brain
Kok Pin Ng et al.
ALZHEIMERS RESEARCH & THERAPY (2017)
Tau Pathology Distribution in Alzheimer's disease Corresponds Differentially to Cognition-Relevant Functional Brain Networks
Oskar Hansson et al.
FRONTIERS IN NEUROSCIENCE (2017)
Biochemically-defined pools of amyloid-β in sporadic Alzheimer's disease: correlation with amyloid PET
Blaine R. Roberts et al.
BRAIN (2017)
Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition
Michael J. Pontecorvo et al.
BRAIN (2017)
Defining imaging biomarker cut points for brain aging and Alzheimer's disease
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2017)
Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease
Rik Ossenkoppele et al.
BRAIN (2016)
An autoradiographic evaluation of AV-1451 Tau PET in dementia
Val J. Lowe et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2016)
The Centiloid Project: Standardizing quantitative amyloid plaque estimation by PET
William E. Klunk et al.
ALZHEIMERS & DEMENTIA (2015)
The influence of biological and technical factors on quantitative analysis of amyloid PET: Points to consider and recommendations for controlling variability in longitudinal data
Mark E. Schmidt et al.
ALZHEIMERS & DEMENTIA (2015)
Primary age-related tauopathy (PART): a common pathology associated with human aging
John F. Crary et al.
ACTA NEUROPATHOLOGICA (2014)
Modeling regional vulnerability to Alzheimer pathology
Donald R. Royall et al.
NEUROBIOLOGY OF AGING (2012)
Amyloid Imaging Liberal or Conservative? Let the Data Decide
William J. Jagust
ARCHIVES OF NEUROLOGY (2011)
Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study
Melissa E. Murray et al.
LANCET NEUROLOGY (2011)
Testing the Right Target and Right Drug at the Right Stage
Reisa A. Sperling et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
分享论文
